Tilray's Wild Ride: Cannabis Bill Boosts Stock Amidst Headwinds
Update: 2025-09-12
Description
Tilray stock jumped 5% on news of a House committee protecting state medical marijuana programs, but don't get too excited. Despite this boost, Tilray's facing major headwinds: a canceled DOJ cannabis rule, potential reverse stock split, and a massive $1 billion quarterly loss. Is this rally a blip in Tilray's volatile journey, or a sign of real change in the cannabis sector?
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
